My Retina Tracker Program
The Foundation Fighting Blindness, in partnership with Blueprint Genetics and InformedDNA®, offers an open access, no-cost genetic testing program called the My Retina Tracker® Program. This program is for individuals living in the United States, with a clinical diagnosis of an inherited retinal degeneration (IRD). The revised eligibility criteria are listed below in ”Who is Eligible for Testing.”
The program offers people with an IRD access to the highest quality genetic testing and genetic counseling. Although it is not required for participation, this program offers an easy opportunity to join the My Retina Tracker Registry. This gives individuals the opportunity to contribute to research, development and the opportunity of being contacted about relevant clinical trials.
The program provides patients with a 322-gene panel targeting relevant genes associated with IRD. Unique features of the panel include the entire mitochondrial genome, full RPGR coverage, high resolution copy number variant detection and comprehensive coverage of IRD-related non-coding variants. The program offers no-charge genetic counseling through InformedDNA, the leader in counseling individuals and families affected by IRD.
Ordering is easy through Blueprint’s online portal, Nucleus. Results can be viewed in Nucleus approximately 4 weeks after Blueprint Genetics receives the sample.
Interested in learning more? In our recent webinar, the program is introduced in more detail.
Why select My Retina Tracker Program for your patient with an IRD?
- The program is based on an existing My Retina Tracker Registry study that has been developed and utilized by leaders in the field of IRD genetics and therapeutics.
- To date, over 6,000 people with IRD have participated in this program, leading to a powerful genotype/phenotype database. Experienced genetic counselors to help guide your patients through the testing process.
- The genetic test represents the best IRD diagnostic panel on the market today. It includes excellent coverage of the essential RPGR gene, including the ORF15 difficult-to-analyze region, analysis of the entire mitochondrial genome, high-resolution copy number variant (CNV) detection and known disease-causing noncoding variants.
- Eligible individuals also receive no-charge genetic counseling through InformedDNA whose genetic counselors are experienced in providing genetic test interpretation and counseling to thousands of patients with IRD in comprehensive, individualized sessions.
- Your patient has the opportunity to enroll in the Foundation Fighting Blindness My Retina Tracker Registry during the counseling session and in doing so support research, development in the field of IRD diagnostics, and have the opportunity of being contacted about relevant clinical trials.